EuCorVac-19

EuCorVac-19

Vaccine description
Target	SARS-CoV-2
Vaccine type	Protein subunit
Clinical data
Routes of administration	Intramuscular

EuCorVac-19 is a COVID-19 vaccine candidate developed by EuBiologics Co.^[1][2][3][4]

Clinical trials

Phase I/II

EuBiologics Co., Ltd started the study on February 23, 2021.^[5] The study is titled "Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults"^[5] As of April 26, 2021, the trial is ongoing, and participants are being accepted. It has an expected primary completion date of March 2022. The study is anticipated to be completed in January 2023.^{[citation needed]}

Phase III

EuBiologics registered a phase III trial with a starting date of October 1, 2022 in the Philippines.^[6]

References

DevelopmentClassesAdministrationVaccines

Bacterial	Anthrax Brucellosis Cholera# Diphtheria# Hib# Leptospirosis Lyme disease‡ Meningococcus# MeNZB NmVac4-A/C/Y/W-135 Pertussis# Plague Pneumococcal# PCV PPSV Q fever Tetanus# Tuberculosis BCG# Typhoid# Ty21a ViCPS Typhus combination: DPT/DTwP/DTaP Td/Tdap research: Clostridioides difficile Group B streptococcal disease Shigellosis
Viral	Adenovirus Chikungunya Ebola rVSV-ZEBOV Flu# H1N1 (Pandemrix) H5N1 LAIV Hantavirus Hepatitis A# Hepatitis B# Hepatitis E HPV# Cervarix Gardasil Japanese encephalitis# Measles# Mumps# Polio# Sabin Salk Rabies# Rotavirus# Rubella# SARS-CoV-2 Corbevax† Bharat Biotech† CanSino† CoronaVac† EpiVacCorona† Janssen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK† Sinopharm BIBP† Skycovione† Sputnik V† Valneva† Respiratory syncytial virus (RSV) Smallpox Tick-borne encephalitis# Varicella zoster Chicken pox# Shingles Yellow fever# combination: Hepatitis A and B MMR MMRV research: Cytomegalovirus Dengue# Epstein–Barr virus Hepatitis C Herpes simplex HIV Zika
Protozoan	Malaria RTS,S research: Trypanosomiasis
Helminthiasis	research: Hookworm Schistosomiasis
Other	Androvax (androstenedione albumin) Cancer vaccines ALVAC-CEA BCG# Hepatitis B# HPV# Cervarix Gardasil Prostvac NicVAX Ovandrotone albumin (Fecundin) TA-CD TA-NIC combination: DTaP-IPV/Hib DTaP-IPV-HepB DTwP-HepB-Hib Hexavalent vaccine

Inventors/
researchersControversyRelated